巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Precipio

    PRPO
    1.080
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Precipio - 延遲價格・最後更新於 20/05 12:15
    最高位
    1.080
    最低位
    1.060
    開市價
    --
    前收市價
    1.080
    成交量(千)
    0.36
    成交額(百萬)
    0.00
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    24.53
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    4.650 - 0.910
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Precipio
    證券代碼
    PRPO.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.
    發行量
    22708708
    公司總部
    4 Science Park
    公司網址
    https://www.precipiodx.com
    公司電郵
    investor.relations@transgenomic.com
    公司電話
    +1 203 787-7888
    暫無內容

    關於

    Precipio(PRPO.US)所屬的行業板塊為Diagnostics & Research。
    Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.
    詳細公司背景可參考: https://www.precipiodx.com